Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Mohrs, Oliver K ^a,b   Wunderlich, Nina ^c   Petersen, Steffen E ^d   Pottmeyer, Anselm ^a   Kauczor, Hans Ulrich ^b  

^a Alice Hospital Darmstadt   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Cardio Vascular Center (CVC)   (Germany)

^d LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOTERATE MEGLUMINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM 1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETATE; GADOTERIC ACID; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTICLE; ARTIFACT; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEASIBILITY STUDY; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART CATHETER; HEART CATHETERIZATION; HEART LEFT ATRIUM; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; THREE DIMENSIONAL ECHOCARDIOGRAPHY; COMPUTER ASSISTED DIAGNOSIS; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROSTHESIS; PROSTHESIS FAILURE; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

AGED; ARTIFACTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; HEART CATHETERIZATION; HETEROCYCLIC COMPOUNDS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; ORGANOMETALLIC COMPOUNDS; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; TREATMENT OUTCOME;

EID: 80053487803     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-33     Document Type: Article

References (22)

1. Non-valvular atrial fibrillation and stroke prevention. National blood Pressure Advisory Committee of the National Heart Foundation. Hankey GJ, Med J Aust 2001 174 5 234 239 11280695
2. Relationship between left atrial appendage function and left atrial thrombus in patients with nonvalvular chronic atrial fibrillation and atrial flutter. Narumiya T, Sakamaki T, Sato Y, Kanmatsuse K, Circ J 2003 67 68 72 10.1253/circj.67.68 12520155 (Pubitemid 36119624)
3. A transesophageal echocardiographic study on risk factors for stroke in elderly patients with atrial fibrillation: a comparison with younger patients. Shinokawa N, Hirai T, Takashima S, Chest 2001 120 840 846 10.1378/chest.120.3. 840 11555518 (Pubitemid 32885458)
4. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Blackshear JL, Odell JA, Ann Thorac Surg 1996 61 2 755 761 10.1016/0003-4975(95)00887-X 8572814 (Pubitemid 26060923)
5. Atrial fibrillation, transesophageal echo, electrical cardioversion, and anticoagulation. Manning WJ, Clin Cardiol 1995 18 2 58 10.1002/clc.4960180203 7720289
6. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism -first experience in canine model. Nakai T, Lesh MD, Gerstenfeld EP, Virmani R, Jones R, Lee RJ, Circulation 2002 105 2217 2222 10.1161/01.CIR.0000015605.30810.51 11994258 (Pubitemid 34517168)
7. Percutaneous left atrial appendage occlusion to prevent stroke in high-risk patients with atrial fibrillation -early clinical experience. Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della Bella P, Nakai T, Reisman M, DiMario C, Block P, Kramer P, Fleschenberg D, Krumsdorf U, Scherer D, Circulation 2002 105 1887 1889 10.1161/01.CIR.0000015698.54752.6D 11997272 (Pubitemid 34437613)
8. Mechanical occlusion of the left atrial appendage. Omran H, Hardung D, Schmidt H, Hammerstingl C, Lüderitz B, J Cardiovasc Electrophysiol 2003 14 56 59 10.1046/j.1540-8167.14.s9.11.x
9. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Onalan O, Crystal E, Stroke 2007 38 2 624 30 10.1161/01.STR.0000250166.06949.95 17261703 (Pubitemid 46184230)
10. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. Bayard YL, Omran H, Neuzil P, Thuesen L, Pichler M, Rowland E, Ramondo A, Ruzyllo W, Budts W, Montalescot G, Brugada P, Serruys PW, Vahanian A, Piéchaud JF, Bartorelli A, Marco J, Probst P, Kuck KH, Ostermayer SH, Büscheck F, Fischer E, Leetz M, Sievert H, Euro Intervention 2010 6 2 220 226 20562072
11. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M, JACC Cardiovasc Interv 2009 2 7 594 600 10.1016/j.jcin.2009.05.005 19628179
12. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, PROTECT AF Investigators, Lancet 2009 374 534 542 10.1016/S0140-6736(09)61343-X 19683639
13. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR, J Am Coll Cardiol 2007 49 13 1490 1495 10.1016/j.jacc.2007.02.035 17397680 (Pubitemid 46505070)
14. Dynamic contrast-enhanced MRI before and after transcatheter occlusion of a patent foramen ovale. Mohrs OK, Petersen SE, Erkapic D, Victor A, Schlosser T, Nowak B, Voigtlaender T, Kauczor HU, Am J Roentgenol 2007 188 3 844 849 10.2214/AJR.06.0489
15. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE, JAMA 2001 285 18 2370 2375 10.1001/jama.285.18.2370 11343485 (Pubitemid 32424106)
16. Hemorrhagic complications of anticoagulant treatment. Levine MN, Raskob G, Landefeld S, Kearon C, Chest 2001 119 1 108 121 10.1378/chest.119.1-suppl. 108S
17. Echocardiographic assessment of the left atrial appendage. Agmon Y, Khandheria BK, Gentile F, Seward JB, J Am Coll Cardiol 1999 34 7 1867 1877 10.1016/S0735-1097(99)00472-6 10588196 (Pubitemid 30002637)
18. Analysis of in vivo left atrial appendage morphology in patients with atrial fibrillation: a direct comparison of transesophageal echocardiography, planar cardiac CT, and segmented three-dimensional cardiac CT. Budge LP, Shaffer KM, Moorman JR, Lake DE, Ferguson JD, Mangrum JM, J Interv Card Electrophysiol 2008 23 2 87 93 10.1007/s10840-008-9281-7 18686024
19. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Veinot JP, Harrity PJ, Gentile F, Khandheria BK, Bailey KR, Eickholt JT, Seward JB, Tajik AJ, Edwards WD, Circulation 1997 96 9 3112 3115 9386182 (Pubitemid 27500115)
20. Atrial structure and fibres: morphologic bases of atrial conduction. Ho SY, Anderson RH, Sánchez-Quintana D, Cardiovasc Res 2002 54 2 325 336 10.1016/S0008-6363(02)00226-2 12062338 (Pubitemid 34327912)
21. Ex vivo evaluation of ferromagnetism and artifacts of cardiac occluders exposed to a 1.5-T MR system. Shellock FG, Morisoli SM, J Magn Reson Imaging 1994 4 2 213 215 10.1002/jmri.1880040220 8180463
22. MRI safety aspects and artifacts of atrial septal defect and patent foramen ovale occluders at 1.5 tesla: a phantom study. Bock M, Mohrs OK, Voigtlaender T, Kauczor HU, Semmler W, Rofo 2006 178 3 272 7 16508833 (Pubitemid 43381906)